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Abstract
Actinobacillus actinomycetemcomitans was acquired by captive Macaca fascicularis 3 to 6 months after
birth, and all monkeys aged over 6 months harbored detectable levels. This microorganism was most
frequently isolated from the gingival plaque of the incisor (and other) teeth compared with other oral
sites. Strains were leukotoxic by bioassay and Western blot analysis. Antibodies in macaque serum
contained neutralized the leukotoxin of a human A. actinomycetemcomitans strain. High titres of
maternal neutralizing anti-leukotoxin antibodies were detected in neonates; the titre then fell rapidly so
that by 6 months the antibody titer was zero. Antileukotoxin antibody production was detected after 6
months of age, rapidly reaching a high level within 2 years after birth. The presence of leukotoxic strains
of A. actinomycetemcomitans in the gingival region did not appear to be correlated with an increase in
susceptibility to periodontal disease.
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Intra-oral colonization of macaque monkeys by Actinobacillus
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Abstract
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Actinobacillus actinomycetemcomitans was acquired by captive Macaca fascicularis 3 to 6 months
after birth, and all monkeys aged over 6 months harbored detectable levels. This microorganism
was most frequently isolated from the gingival plaque of the incisor (and other) teeth compared
with other oral sites. Strains were leukotoxic by bioassay and Western blot analysis. Antibodies in
macaque serum contained neutralized the leukotoxin of a human A. actinomycetemcomitans
strain. High titres of maternal neutralizing anti-leukotoxin antibodies were detected in neonates;
the titre then fell rapidly so that by 6 months the antibody titer was zero. Antileukotoxin antibody
production was detected after 6 months of age, rapidly reaching a high level within 2 years after
birth. The presence of leukotoxic strains of A. actinomycetemcomitans in the gingival region did
not appear to be correlated with an increase in susceptibility to periodontal disease.
Keywords
non-human primates; Actinobacillus actinomycetemcomitans; leukotoxin; colonization; maternal
antibody
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Actinobacillus spp. are isolated from the normal oral flora of many animals, including
primates (11, 16), In humans, Actinobacillus actinomycetemcomitans is isolated from the
dental plaque (14, 22) of approximately 25–30% of healthy individuals, but in those with
juvenile periodontitis and severe forms of adult periodontitis the carriage rate is often much
greater (14, 15, 23), The majority of patients (over 90%) with juvenile periodontitis have
raised antibody titres to a potent leukotoxin produced by leukotoxic A.
actinomycetemcomitans strains (20). Production of leukotoxin may represent a virulence
mechanism by destroying the host’s polymorphonuclear leukocytes (PMNs) and monocytes
that migrate locally in response to the microbial attack.
Non-human primates harbor leukotoxic strains of A. actinomycetemcomitans (16) and have
detectable serum antibody titers against the leukotoxin which, in vitro, is lethal for PMNs or
monocytes from many species. The purpose of the present investigation was to obtain more
information on the association of A. actinomycetemcomitans with macaque monkeys. We
have studies the acquisition of leukotoxic strains of A. actinomycetemcomitans and the
dynamics of the immune response to the leukotoxin. The results may eventually be useful in
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explaining why A. actinomycetemcomitans seems to be commensal in most primates but a
potential pathogen in humans.

Material and methods
Animals

$watermark-text

One group of 75 monkeys (Macaca fascicularis) was used in a cross-sectional study to
determine the relationship between the age at which they acquire A. actinomycetemcomitans
and the level of humoral anti-leukotoxin antibodies. The animals ranged from 2 day-old
neonates to adults older than 10 years. Those less than 12 weeks old were breast-fed, the
remainder were fed a variety of diets; Mazuri Primate Diet (Special Diet Services Limited,
Witham, Essex, UK), a high-sucrose cariogenic sandwich diet (3) or a starch-based
maintenance diet (2).
A second group of 10 neonatal monkeys was used to characterize changes in serum antileukotoxin antibody levels during the first 6 months after birth. These animals were breastfed for the first 3–4 months after which they were fed the Mazuri Primate Diet. All animals
had free access to drinking water.
Sera

$watermark-text

Blood was obtained from the femoral artery and sera were separated and frozen at −20°C.
For shipment from the U.K. to Philadelphia small volumes of sera were freeze-dried and
upon arrival reconstituted with distilled water.
Enumeration and identification of A. actinomycetemcomitans
Sterile scalpel blades were used to remove plaque from teeth and the mucosal surfaces were
sampled with sterile cottonwool swabs. The bacteria were dispersed in 2 ml of
Thioglycollate medium without dextrose or indicator, (TG medium, Difco Laboratories,
West Molesey, Surrey, UK), by vigorous vortexing in the presence of sterile glass beads for
15 s. The suspensions were decimally diluted in the same medium. Duplicate, 0.1 ml
aliquots of appropriate dilutions on to horse blood agar base (Oxoid, Ltd., Basingstoke,
Hampshire, UK) supplemented with 5% (v/v) horse blood and menadione at 0.5 µg per ml
and incubated anaerobically at 37°C for 5 days. A. actinomycetemcomitans was isolated on
the medium described by Slots (12), which we (data not shown) and others (21) have found
to be superior to that reported by Mandell and Socransky (9).

$watermark-text

Colonies having the characteristic appearance of A. actinomycetemcomitans (12, 13) were
enumerated by microscopic examination of the selective medium and usually 5 presumptive
A. actinomycetemcomitans colonies were subcultured from each sample. These isolates
were evaluated for acid production from glucose, sucrose, lactose, fructose, xylose,
mannitol, mannose and dextrin, for nitrate reduction, for catalase production and for growth
stimulation by X and V factors (4, 13). The number of A. actinomycetemcomitans was
expressed as a percentage of the total colony count on the non-selective medium.
Cross-sectional study of A. actinomycetemcomitans
Dental plaque was removed from the labial surfaces of the upper central incisor teeth at the
gingival margin of monkeys aged from 4 weeks to over 10 years. These sites were chosen as
the incisors are the first teeth to erupt (at between 3 and 4 weeks of age) permitting
uniformity of sampling site on the deciduous teeth from a very young age, and from the
same site on the central incisor teeth of the permanent dentition of older animals. The
mucosae of the edentulous neonatal monkeys were sampled with cotton wool swabs. The
proportion of A. actinomycetemcomitans in each sample was determined.
Oral Microbiol Immunol. Author manuscript; available in PMC 2012 December 07.
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Intra-oral localization of A. actinomycetemcomitans
From 10 juvenile monkeys, aged 18–24 months, forming part of the group used in the crosssectional study, plaque samples were taken from (a) the palatal groove on the first left
maxillay deciduous molar tooth, (b) the gingival margin of the labial surfaces of the upper
deciduous central incisor tooth (c) the dorsum of the tongue (d) the cheeks and (e) the hard
palate. The mean proportion of A. actinomycetemcomitans at each site determined.
Estimation of anti-leukotoxin antibody activity in sera

$watermark-text

The anti-leukotoxin titers of sera were determined from 46 monkeys investigated in the
cross-sectional study and in sera taken at intervals during the first 6 months after birth from
the 10 neonatal monkeys.

$watermark-text

A bioassay as described by Tsai et al. (19) was employed to ascertain whether sera
neutralized the leukotoxin. Previous studies have established that toxin-neutralization in
human (10) or cynomolgus monkey (17) sera was principally due to IgG antibody activity.
In brief, serial two-fold dilutions of serum (25 µl; 1:2-1:512 v/v) were preincubated (5 min.
room temperature) with an LD90 dose of leukotoxin (100 µl) in 96-well round bottom
microtiter plates (Linbro, Titertek, McLean, VA). The leukotoxin preparation was a sonic
extract prepared from human A. actinomycetemcomitans strain JP2 (19). Human PMNs prelabelled with Na2 51Cr O4 (New England Nuclear, Boston, MA) were added (5 × 105 PMNs
in 75 µl Hanks balanced salt solution containing 0.1% gelatin) to the toxin-serum mixtures
and incubated at 37°C in 5% CO2–95% air for 45 min. Following centrifugation to deposit
cells, the amount of label released into the ambient medium was measured by gamma
spectroscopy. Controls consisted of: cells in medium alone; cells exposed to toxin in the
presence of varying dilutions of a rabbit polyclonal toxin-neutralizing antiserum, or varying
dilutions of a pool of normal human AB serum which had no neutralizing activity. All
experiments were conducted in triplicate. Toxin inhibitory activity was expressed as the
reciprocal dilution of serum required to protect 50% of the cells exposed to the LD90 dose of
leukotoxin.
Immunublot analysis of sera for anti-leukotoxin activity
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Western blot analysis was employed to detect immunologically anti-leukotoxin antibody in
sera. Leukotoxin was extracted from A. actinomycetemcomitans strain JP2 by osmotic
shock (6), solubilized by dilution (1:1) in a solution containing 0.16 M Tris.HCl (pH 6.8),
4% sodium dodecyl sulphate and 20% glycerol and heated at 50°C for 20 min.
Electrophoresis was performed as described previously (5) on 17.5% SDS-polyacrylamide
gel slabs and blotted onto nitrocellulose as described by Towbin et al. (18). The blot was cut
into longitudinal strips and each strip was incubated with an individual serum sample,
previously diluted 1:10 in 10 mM Tris.HCl (pH 7.4) containing 0.9% NaCl, 3% bovine
serum albumin and 10% normal rabbit serum, over-night at room temperature. Human
juvenile periodontitis serum and a monoclonal antibody against the leukotoxin (6) were
included as controls. All strips were washed and incubated with peroxidase conjugated antihuman or anti-mouse immunoglobulin (Cooper Biochemical, Malvern, PA) at 1:2000 for 2 h
at room temperature, washed and developed with o-dianisidine (18).
Testing of A. actinomycetemcomitans isolates for leukotoxic activity
For biological testing, A. actinomycetemcomitans isolates were grown for 24 h in 100 ml
peptone-yeast extract broth (7) supplemented with 0.4% bicarbonate in 10% CO2–90% air at
35°C. Organisms were washed twice with PBS by centrifugation. Leukotoxic activity was
estimated using human blood PMNs or HL-60 leukemia cells (pre-labelled with 51Cr) as
target cells (see above). Freshly harvested bacteria were added to labelled cells (5 to 200
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organisms per cell) for 45 min at 37°C. Controls consisted of: cells in buffer without
bacteria; cells exposed to A. actinomycetemcomitans human strains JP2 or Y4 (positive
controls); cells incubated with heated organisms (60°C, 30 min; negative controls).
Immunoblot analysis of extracts of A. actinomycetemcomitans

$watermark-text

A. actinomycetemcomitans (human strain JP2) and representative isolates of this organism
from the macaques were grown in broth as described above and sonicated at 4°C, cleared by
centrifugation (12,000 × g) and the proteins solubilized and electrophoresed as described
above. The proteins were transferred to nitrocellulose and the blot was incubated with
monoclonal antibody specific for the leukotoxin of human A. actinomycetemcomitans
(strain Y4) [6]. The blot was processed as described previously (18).

Results
Identification of A. actinomycetemcomitans
None of the isolates identified as A. actinomycetemcomitans produced acid from dextrin,
lactose, sucrose or xylose: all produced acid from glucose, maltose and fructose;
fermentation of mannitol was variable and a small number of isolates did not ferment
mannose. All produced catalase and none was stimulated by either X or V factor and nitrate
was reduced.
Cross-sectional study of A. actinomycetemcomitans in the mouth

$watermark-text

A. actinomycetemcomitans was not identified in gingival plaque or oral mucosal samples
obtained from any of the 13 animals aged less than 8 weeks of age (Table 1). The organism
was first detected at the gingival margin of the central incisor teeth in 2 of 4 monkeys aged
between 9 and 12 weeks and in 7 of 8 monkeys aged between 3 and 6 months. All 50
monkeys over 6 months old harbored A. actinomycetemcomitans in plaque collected from
the gingival margins.
It should be noted that there was no obvious correlation between the periodontal status of the
gingival sampling sites and the presence of these organisms: A. actinomycetemcomitans was
isolated from sites with healthy as well as inflamed gingival tissues. In no instance did the
sampled areas exhibit an increase in probable pocket depth or other clinical signs of
progressive, destructive periodontitis.

$watermark-text

The median proportion of A. actinomycetemcomitans was 0.7% of the total cfu in animals
aged from 3 to 6 months. This figure increased significantly to 2.8% in monkeys aged 6 to
12 months and to 4.4% in those animals over 1 year old.

A. actinomycetemcomitans constituted greater than 5% (Table 1) of the total cfu in plaque
from 21 to the 62 monkeys 9 weeks of age or older.
Intra-oral distribution
A. actinomycetemcomitans was not isolated from the palatal grooves of the first maxillary
molar tooth of any of the 10 monkeys (age 18 to 24 months) and the frequency of isolation
from various intra-oral mucosal surfaces was low (Table 2). However, as expected from the
results of the cross-sectional study (above) A. actinomycetemcomitans were isolated from
the gingival margin of the incisor teeth of each monkey.
Leukotoxic activity of macaque A. actinomycetemcomitans isolates
Four strains of A. actinomycetemcomitans from different monkeys were tested for their
ability to kill human PMNs or HL-60 tumor cell lines. All macaque isolates were cytotoxic,
Oral Microbiol Immunol. Author manuscript; available in PMC 2012 December 07.
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causing dose-dependant destruction of target cells (Fig. 1). Biological activity was abolished
by heating the organisms to 60°C for 30 min (data not shown).
Anti-leukotoxin activity in macaque sera
In cross-sectional studies median anti-leukotoxin antibody titers were initially high (range
30–220) in monkeys aged between 0–4 weeks, then fell reaching a low point at about 26
weeks (Fig. 2). Subsequently, the level of the toxin neutralizing activity very rapidly rose
until the median titer for monkeys aged over 2 years was > 512 (Fig. 2).

$watermark-text

The anti-leukotoxin antibody profile during the first 6 months of life was investigated more
closely in a longitudinal study and median titers are shown in Fig. 3. The antibody titer was
initially high at birth (range 86–460) and then rapidly fell reaching a median titer of zero
between 21 and 24 weeks. A. actinomycetemcomitans strains were not isolated from infant
monkeys until they were at least 10 weeks old (data not shown).
Immunoblot analysis of sera for anti-leukotoxin activity—Murine monoclonal
antibody to A. actinomycetemcomitans leukotoxin, and antibody in 2 human juvenile
periodontitis sera and in both of the 2 monkey sera examined, detected the same antigenic
moiety in A. actinomycetemcomitans strain JP2 (Fig. 4).

$watermark-text

Immunoblot analysis of macaque A. actinomycetemcomitans for leukotoxin—
Fig. 5 shows the proteins of 4 macaque strains and human JP2 strain of A.
actinomycetemcomitans separated using SDS-polyacrylamide gel electrophoresis and
probed with a monoclonal antibody raised against the JP2 leukotoxin. In strains B4 and B6
strong bands corresponding to leukotoxin are present while C2 and C7 also have a band at
the same position on the gel but it is somewhat weaker. These results correlate with those
obtained when these organisms were tested for biological activity (above): strains B4 and B6
were more potent in destroying target cells when compared to equivalent numbers of strains
C2 and C7.

Discussion

$watermark-text

Actinobacillus spp. are members of the oral flora of many animals (11). The data presented
here clearly demonstrate that A. actinomycetemcomitans is routinely isolated from the the
dental plaque of Macaca fascicularis and confirm previous observations that A.
actinomycetemcomitans is a commensal of most non-human primates (16). Whether A.
actinomycetemcomitans is a commensal of humans or an exogenous pathogen is not cler;
however it is present in the dental plaque of a significant proportion of healthy individuals
(14, 22).
Incisor teeth of macaque monkeys erupt when the animals are between 3 and 4 weeks of age
and A. actinomycetemcomitans is first acquired some weeks after tooth eruption. Thus, no
monkey harbored A. actinomycetemcomitans until at least 4–5 weeks after the eruption of
the incisor teeth. Similar studies of the colonization of the teeth of macaques by
Actinomyces viscosus and Actinomyces naeslundii (which are also normal members of the
dental plaque flora), demonstrated a different pattern of acquisition (1). Actinomyces were
present on the incisor teeth within 7 days of tooth eruption. The reasons for the slower
colonization of the teeth by A. actinomycetemcomitans when compared to Actinomyces is
not clear but may include a requirement for bacterial species with which the actinobacillus
can co-aggregate. It may also be of importance that the time of actinobacillus colonization
coincides with the period when the young monkeys start to reduce their intake of milk so
reducing the potential influence of maternal s-IgA on colonization. Cessation of breast
feeding is also associated with an increased consumption of prepared diet; in this case
Oral Microbiol Immunol. Author manuscript; available in PMC 2012 December 07.
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usually the Mazuri diet (see Materials and Methods). Clearly significant changes to the oral
environment occur simultaneously with the acquisition of A. actinomycetemcomitans, the
importance of any one of them cannot be determined from the present study. The persistance
of A. actinomycetemcomitans in the plaque of juveniles and adults was not related to the
diet consumed (data not shown).

$watermark-text

The role of maternal antibody in determining the resistance of the infant monkeys to
colonization by A. actinomycetemcomitans is not clear because we do not know whether
antibodies reactive with leukotoxin or other cellular components are able to interfere with
the establishment of A. actinomycetemcomitans in neonatal monkeys. However, it is
noteworthy that colonization occurred when the titer of maternal anti-leukotoxin antibody
was declining or undetectable. It is also likely that maternal antibodies reactive with other
actinobacillus antigens also were at a low level at the same time. As A.
actinomycetemcomitans was harbored by each mother it is reasonable to assume that the
organisms were derived from their mothers.

$watermark-text

The present data suggest that the gingival margin is the major intra-oral habitat of A.
actinomycetemcomitans in macaque monkeys. These findings are similar to those of Slots et
al. (14) who isolted A. actinomycetemcomitans primarily from dental plaque in the gingival
crevice region of periodontally healthy humans. The presence of A. actinomycetemcomitans
on the dentition is not surprising as they are able to form adherant plaque in vitro (8). The
preferential colonization of this niche by A. actinomycetemcomitans could be due to
localization of substrates, essential for its growth, derived from the host via the gingival
crevice or from other members of the gingival microflora. At present the nutritional
requirements of A. actinomycetemcomitans growing in vivo are not known.
Western blot analysis demonstrated the presence of leukotoxin in representative strains of
macaque A. actinomycetemcomitans and that macaque sera contained antibody that reacted
with leukotoxin from a human A. actinomycetemcomitans strain. Further, monkey sera
neutralized the biological activity of the leukotoxin. These observations together with the
ability of macaque strains to kill human PMNs strongly suggest that isolates from monkeys
produce a biologically active molecule with properties very similar to those of the
leukotoxin from human strains of A. actinomycetemcomitans. In fact by all the criteria used
in our study the macaque A. actinomycetemcomitans strains also were similar to those
isolated from humans (13).

$watermark-text

There are considerable data to suggest that A. actinomycetemcomitans may be of pathogenic
significance in the development of destructive periodontitis in humans (14, 15, 23).
However, this would not appear to be the case in macaques. There may be several
explanations for the apparent difference in the nature and possible consequences of A.
actinomycetemcomitans colonization in humans versus macaques, and other non-human
primates. If A. actinomycetemcomitans leukotoxin represents one potential virulence
mechanism in humans then it is of significance that monkeys begin to harbor leukotoxic
strains within weeks of tooth eruption, yet appear to suffer no untoward effects. This may be
a consequence of at least 2 variables. First, monkey PMNs are significantly less sensitive to
A. actinomycetemcomitans leukotoxin when compared to human PMNs (16). Thus the level
of infection and/or availability of the A. actinomycetemcomitans leukotoxin requited to kill
enough PMNs to depress antibacterial defences in the monkey gingival crevice may be
higher than that needed in humans. Second, the immune response to the leukotoxin may be
instrumental in protecting these animals against A. actinomycetemcomitans. At birth they
are passively immunized by maternal antibody and by 1 year of age virtually all have
actively responded to antigenic stimulation having relatively high titers of toxin-neutralizing
antibodies for the rest of their lives. It is only for a short period (between 4 and 8 months of
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age) that the antibody levels appear to be extremely low. The decline in maternal antibody
titer to the toxin (and presumably other A. actinomycetemcomitans antigens) corresponds to
the time when the deciduous dentition erupts and when A. actinomycetemcomitans is first
detected in the gingival crevice in these animals. This temporary lapse in antibody activity
may provide A. actinomycetemcomitans with the opportunity to become established in the
host. However, the dynamics and the intensity of the host’s immune response to the
leukotoxin (as well as other potential virulence factors) may prevent the development of
clinically detectable disease at colonized sites.

$watermark-text

Little is known about the dynamics of A. actinomycetemcomitans infection or the immune
response to this organism in humans. We believe that comparative studies of host-A.
actinomycetemcomitans interrelationships in non-human primates may help to provide clues
to better understand why A. actinomycetemcomitans is a commensal of both humans and
non-human primates but a potential periodontopathogenic organism only in humans.
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Fig. 1.

Leukotoxic activity of A. actinomycetemcomitans isolated from macaques and humans.
Freshly cultured organisms derived from humans (strain JP2) and from macaques (strains
B6, B4, C2, and C7) were washed and incubated with 51Cr-labelled human PMNs (5–200
per PMN). The amount (per cent of total) of 51Cr released from the target cells into the
medium is a reflection of the leukotoxic activity of the isolates.
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Fig. 2.

Median anti-leukotoxin antibody titers in the sera of individual monkeys of various ages,
from neonates to adults. The anti-leukotoxin titer represents the reciprocal of the dilution of
serum which inhibited 50% release of 51Cr from prelabelled PMNs exposed to an LD90 dose
of A. actinomycetemcomitans leukotoxin (see Material and methods).
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Fig. 3.

Longitudinal changes in the median anti-leukotoxin antibody titer in the serum of a group of
10 neonatal monkeys up to the age of 24 weeks. The anti-leukotoxin titer represents the
reciprocal of the dilution of serum which inhibited 50% release of 51Cr from prelabelled
PMNs exposed to an LD90 dose of A. actinomycetemcomitans leukotoxin (see Material and
methods).
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Fig. 4.

Screening of cynomolgus monkey sera for anti-leukotoxin antibodies. An osmotic shock
extract of A. actinomycetemcomitans Y4 was applied to multiple lanes of an SDSpolyacrylamide gel and the separated proteins were transferred to nitrocellulose. The filter
was cut into strips and each strip was incubated with sera (1:10 dilution) from human
juvenile periodontitis patient or from macaque monkeys. The strips were then incubated
with peroxidase-conjugated reporter antibody (1:2000 dilution). Lane A, monoclonal
antibody to leukotoxin from human A. actinomycetemcomitans Y4; lanes B and C, human
serum; lanes D and E, monkey serum.
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Fig. 5.

Western blot analysis of cellular proteins from A. actinomycetemcomitans isolated from
cynomolgus monkeys. The bacteria were lysed by sonication, the proteins were separated by
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose. Leukotoxinspectific monoclonal antibody made against toxin from the human strain Y4 was used at a
1:1000 dilution. Peroxidase-conjugated reporter antibody (1:2000 dilution) was used to
visualize the reaction. Lane A, human strain JP2; lane B, strain B4; lane C, strain B6; lane
D, strain C2; lane E, strain C7. The strains examined in lanes B–E were isolated from the
macaque monkeys described in Material and methods.
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Table 1
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The age-realted frequency of isolation and proportion of A. actinomycetemcomitans in the dental plaque of
macaque monkeys.
Frequency of
Age of monkey

Percent of total cfu

No.

isolation (%)

Median

Range

<4 weeks

7

0

< 0.001

–

4–8 weeks

6

0

< 0.001

–

9–12 weeks

4

50

<0.01

< 0.001–0.55

3–6 months

8

87

0.7

< 0.001–7.0

6–12 months

16

100

2.8

0.09–50.0

>1 year

34

100

4.35

0.2–40.0
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Table 2

The intra-oral distribution of A. actinomycetemcomitans in 10 macaque monkeys aged 18–24 months

$watermark-text

Percent of
sites
Intra-oral site

positive

Incisor gingival margin

Median

Range

10.3

1.5–36.0

0

< 0.001

nc

Tongue dorsum

40

< 0.002

<0.001–0.21

Hard palate

50

< 0.01

< 0.001–0.30

Cheek

40

< 0.001

<0.001–0.13

Molar palatal groove

100

Percent of total cfu

Nc = not calculable.
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